Early minor stimulation of microglial TLR2 and TLR4 receptors attenuates Alzheimer's disease-related cognitive deficit in rats: behavioral, molecular, and electrophysiological evidence

Neurobiology of Aging
Hamid Gholami PourbadieMohammad Ali Shokrgozar

Abstract

At early stages of Alzheimer's disease (AD), soluble amyloid beta (Aβ) accumulates in brain while microglia are in resting state. Microglia can recognize Aβ long after formation of plaques and release neurotoxic mediators. We examined impact of early minor activation of microglia by Toll-like receptors (TLRs) 2 and 4 agonists on Alzheimer's disease-related disturbed synaptic function and spatial memory in rats. Microglial BV-2 cells were treated by 0.1, 1, and 10 μg/mL of the TLRs ligands lipopolysaccharide, monophosphoryl lipid A (MPL), and Pam3Cys for 24 hours. Culture medium was then changed with media containing 1-μM Aβ. Tumour necrosis factor (TNF)-α and CCL3 levels were measured in the supernatant, 24 hours thereafter. One μg of TLRs ligands which was able to release low level of TNF-α and CCL3, was administered intracerebroventricularly (i.c.v) to adult male rats every 3 days for 24 days. At the half of the treatment period, Aβ1-42 was infused i.c.v (0.075 μg/hour) for 2 weeks. Finally, the following factors were measured: memory performance by Morris water maze, postsynaptic potentials of dentate gyrus following perforant pathway stimulation, hippocampal inflammatory cytokines interleukin 1 (IL-1)β and TNF-α, anti-infla...Continue Reading

Citations

Aug 11, 2019·Molecular Neurobiology·María F Zappa VillarPaula C Reggiani
Oct 4, 2019·Expert Opinion on Therapeutic Targets·Gunnar R LeitnerAndis Klegeris
Sep 12, 2019·Frontiers in Pharmacology·Knut BiberThomas Möller
Jan 6, 2019·Journal of Molecular Neuroscience : MN·Niloufar YousefiHamid Gholami Pourbadie
Feb 27, 2020·International Journal of Molecular Sciences·Yu-Chia KaoKuen-Jer Tsai
Aug 10, 2019·Neural Regeneration Research·Wei-Yi Ong, John Jia En Chua
Sep 4, 2020·International Journal of Molecular Sciences·Malena Dos Santos GuilhermeKristina Endres
Jan 5, 2021·Frontiers in Neuroscience·Yongji ZhouCaixiu Lin
Nov 20, 2020·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Wenjun DengChanghong Xing
Jun 2, 2020·Brain, Behavior, and Immunity·Eva M Medina-RodriguezRichard S Jope
Apr 1, 2021·Journal of Neurovirology·Soheil GhassemiMohammad Sayyah
Apr 13, 2021·Frontiers in Cellular Neuroscience·Thomas Ernest James Phillips, Emily Maguire
Jan 1, 2022·Journal of Cellular and Molecular Medicine·Liping ZhaiYu Zhu
Jan 12, 2022·The International Journal of Neuropsychopharmacology·Fu LiChao Huang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.